<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01966965</url>
  </required_header>
  <id_info>
    <org_study_id>ESPX2013</org_study_id>
    <nct_id>NCT01966965</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety Study for PIOLIN® Shampoo</brief_title>
  <acronym>ESPX</acronym>
  <official_title>Phase 3 Efficacy and Safety Study for PIOLIN® Shampoo to Treat Pediculosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Phytopharm Consulting Brazil</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Laboratório Saúde Ltda - principal e único patrocinador</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Phytopharm Consulting Brazil</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to demonstrate the therapeutic efficacy and safety of Shampoo PIOLIN ® in the
      treatment of human pediculosis. Will be treated 212 patients aged 2-60 years with the
      infestation, along with the people in your family life. All will be submitted to the dosing
      regimen recommended in the package insert. 100% of the sample shall be subjected to clinical
      evaluation through comb, pre and post treatment and monitored after thirty days for
      evaluation of safety and possible adverse effects that may arise related to any of the
      components of the formula.

      The efficacy study is active comparator, non-inferiority.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>July 2014</start_date>
  <completion_date type="Anticipated">October 2014</completion_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>EFFICACY</measure>
    <time_frame>17 DAYS</time_frame>
    <description>AFTER 17 DAYS OF TREATMENT PATIENTS SHOULD HAVE NO INFESTATION - clinically</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>SAFETY</measure>
    <time_frame>30 DAYS</time_frame>
    <description>IN THE END OF 30 DAYS TREATMENT PATIENTS WILL BE EVALUATED WITH BLOOD/URINE ANALYSIS FOR CHECKING ANY CHANGE - biochemistry, lab exams</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">212</enrollment>
  <condition>PEDICULOSIS</condition>
  <arm_group>
    <arm_group_label>PIOLIN®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PIOLIN® SHAMPOO 5 DAYS CONTINUOUSLY STOP A WEEK AND APPLY AGAIN</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NEDAX</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>FOLLOWING THE LEAFLET TREATMENT</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>PIOLIN®</intervention_name>
    <description>PIOLIN® SHAMPOO 5 DAYS CONTINUOUSLY STOP A WEEK AND APPLY AGAIN</description>
    <arm_group_label>PIOLIN®</arm_group_label>
    <other_name>RUTA GRAVEOLENS STANDARDIZED FLUID EXTRACT</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>NEDAX</intervention_name>
    <description>AS SPECIFIED AT THE LEAFLET</description>
    <arm_group_label>NEDAX</arm_group_label>
    <other_name>PERMETRIN</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Volunteers healthy female and male ;

          -  Children between 2 and 17 years ;

          -  Increased from 18 years;

          -  Availability of volunteer to maintain a stable weight during the study period (ranging
             from less than 2 kg) ;

          -  Displays lice infestation on clinical examination ;

          -  Voluntary participation ;

          -  Signing the consent form and / or Free and Informed Consent ;

          -  Willingness to comply with study procedures ;

          -  Complying that researchers can make use of all the information nameless , including
             publication and comply with the use and storage of all information confidential .

        Exclusion Criteria:

          -  Use paint or other chemicals on the hair in the last four weeks that precede the study
             ;

          -  Concomitant Therapy ;

          -  Women who are pregnant or intend to become pregnant during the study ;

          -  Infants ;

          -  Volunteers not willing to sign and adhere to the Statement of Consent ;

          -  Known hypersensitivity to the product ;

          -  Participation in any other clinical study ;

          -  Any other condition that the investigator decides that might interfere with the
             results or involving a risk to the volunteer study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>MONICA M MENDES, MD MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>UCPEL-UNIVERSIDADE CATÓLICA DE PELOTAS</affiliation>
  </overall_official>
  <overall_official>
    <last_name>ACHILLES GENTILINI NETO, MD</last_name>
    <role>Study Chair</role>
    <affiliation>INDEPENDENT</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>KARLA F DEUD JOSÉ, PharmD PhD</last_name>
    <phone>55 51 9279-3075</phone>
    <email>karla@phytopharm.com.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Karla F Deud José, PharmD PhD</last_name>
    <phone>55 51 3231-7876</phone>
    <email>karladeud@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ubs Fatima</name>
      <address>
        <city>Pelotas</city>
        <state>RS</state>
        <zip>96075-540</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>MONICA M MENDES, MD MSc</last_name>
      <phone>55 53 9155-2139</phone>
      <email>MONIKETHI@GMAIL.COM</email>
    </contact>
    <investigator>
      <last_name>MONICA M MENDES, MD MSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <link>
    <url>http://lattes.cnpq.br/8425815106310226</url>
    <description>Brazilian researchers and professors site</description>
  </link>
  <verification_date>October 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 17, 2013</study_first_submitted>
  <study_first_submitted_qc>October 17, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 22, 2013</study_first_posted>
  <last_update_submitted>October 22, 2013</last_update_submitted>
  <last_update_submitted_qc>October 22, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 23, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Phytopharm Consulting Brazil</investigator_affiliation>
    <investigator_full_name>Karla F. Deud Jose</investigator_full_name>
    <investigator_title>CEO</investigator_title>
  </responsible_party>
  <keyword>PIOLIN®, PEDICULOSIS, EFFICACY, SAFETY, PHYTOMEDICINE,</keyword>
  <keyword>ARRUDA, RUTA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lice Infestations</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

